Skip to content

Roche presents new data on efficacy of MS treatment Ocrevus

September 3, 2020

Roche said on Thursday new data showed its big-selling multiple sclerosis treatment Ocrevus was a “highly effective treatment option offering a favourable and consistent benefit risk profile”.

The data will be presented at MSVirtual2020 from Sept. 11-13, Roche said in a statement.

It will also present data showing its Enspryng treatment lowered relapse severity in people with Neuromyelitis Optica Spectrum Disorder (NMOSD).

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: